# Biodexa Pharmaceuticals Plc: financial statements, quarterly

BDRX · Nasdaq · CIK 1643918 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bdrx.md) · [Financials](/companies/bdrx/financials.md) · [Filings](/companies/bdrx/filings.md) · [Insiders](/companies/bdrx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bdrx/financials.md?period=annual).

None of the standardized line items are reported.

Shares outstanding: 225,817,808,922 at 2025-12-31, from the cover of the [20-F filed 2026-03-27](/filings/0001214659-26-003921.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.